Hiltzik: The FTC calls foul on pharmacy benefit managers
In 2022, an executive of a big pharmacy middleman firm acknowledged the noxious reality of its business model: It was designed to massively overcharge customers...
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More